Condition: Acute Myeloid Leukemia · Sponsor: University of Freiburg
The white blood cells of patients with acute myeloid leukemia that have undergone allogeneic stem cell transplantation will be investigated. These are patient where the leukemia has returned after the transplantation.
This description comes directly from the study's public registry record.
Robert Zeiser, MD · +4976127034020 · robert.zeiser@uniklinik-freiburg.de
Always discuss trial participation with your own doctor first.
| University of Freiburg Mdical Center | Freiburg im Breisgau, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07627568